Genome‐wide arrays in routine diagnostics of hematological malignancies

Over the last three decades, cytogenetic analysis of malignancies has become an integral part of disease evaluation and prediction of prognosis or responsiveness to therapy. In most diagnostic laboratories, conventional karyotyping, in conjunction with targeted fluorescence in situ hybridization analysis, is routinely performed to detect recurrent aberrations with prognostic implications. However, the genetic complexity of cancer cells requires a sensitive genome‐wide analysis, enabling the detection of small genomic changes in a mixed cell population, as well as of regions of homozygosity. The advent of comprehensive high‐resolution genomic tools, such as molecular karyotyping using comparative genomic hybridization or single‐nucleotide polymorphism microarrays, has overcome many of the limitations of traditional cytogenetic techniques and has been used to study complex genomic lesions in, for example, leukemia. The clinical impact of the genomic copy‐number and copy‐neutral alterations identified by microarray technologies is growing rapidly and genome‐wide array analysis is evolving into a diagnostic tool, to better identify high‐risk patients and predict patients' outcomes from their genomic profiles. Here, we review the added clinical value of an array‐based genome‐wide screen in leukemia, and discuss the technical challenges and an interpretation workflow in applying arrays in the acquired cytogenetic diagnostic setting. Hum Mutat 33:941–948, 2012. © 2012 Wiley Periodicals, Inc.

[1]  Stefan Heinrichs,et al.  SNP array analysis in hematologic malignancies: avoiding false discoveries. , 2010, Blood.

[2]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[3]  A Collins,et al.  13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia , 2011, Leukemia.

[4]  D. Birnbaum,et al.  Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes , 2008, BMC Cancer.

[5]  L. Ding,et al.  Aggressive Chronic Lymphocytic Leukemia with Elevated Genomic Complexity Is Associated with Multiple Gene Defects in the Response to DNA Double-Strand Breaks , 2010, Clinical Cancer Research.

[6]  A. Hagemeijer,et al.  Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. van den Berg,et al.  Microarray‐based genomic profiling as a diagnostic tool in acute lymphoblastic leukemia , 2011, Genes, chromosomes & cancer.

[8]  E. Blennow,et al.  Improved structural characterization of chromosomal breakpoints using high resolution custom array‐CGH , 2010, Clinical genetics.

[9]  M. McDevitt,et al.  250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. , 2008, Cancer research.

[10]  L. Shao,et al.  Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogenetics. , 2010, The Journal of molecular diagnostics : JMD.

[11]  Giuseppe Palumbo,et al.  Broad copy neutral‐loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype‐acute myeloid leukemia genomes , 2010, Genes, chromosomes & cancer.

[12]  T. Barry,et al.  Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia , 2011, International journal of laboratory hematology.

[13]  N. de Leeuw,et al.  SNP Array Analysis in Constitutional and Cancer Genome Diagnostics – Copy Number Variants, Genotyping and Quality Control , 2011, Cytogenetic and Genome Research.

[14]  L. Campbell,et al.  A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. , 2011, Cancer genetics.

[15]  Christopher B. Miller,et al.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. , 2009, The New England journal of medicine.

[16]  W. Lam,et al.  Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes. , 2009, Leukemia research.

[17]  Hanna Göransson,et al.  Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia , 2011, Haematologica.

[18]  J. Bourhis,et al.  Chromosomal Minimal Critical Regions in Therapy-Related Leukemia Appear Different from Those of De Novo Leukemia by High-Resolution aCGH , 2011, PloS one.

[19]  Kerby Shedden,et al.  Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia. , 2010, Blood.

[20]  R. Hills,et al.  Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. , 2010, Blood.

[21]  M. McDevitt,et al.  Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. , 2011, Blood.

[22]  S. Kash,et al.  Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays. , 2010, The Journal of molecular diagnostics : JMD.

[23]  J. Hehir-Kwa,et al.  High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression , 2007, Leukemia.

[24]  J. Vermeesch,et al.  Genome‐wide arrays: Quality criteria and platforms to be used in routine diagnostics , 2012, Human mutation.

[25]  H. Greisman,et al.  Rapid high-resolution mapping of balanced chromosomal rearrangements on tiling CGH arrays. , 2011, The Journal of molecular diagnostics : JMD.

[26]  Michael DiCuccio,et al.  Public data archives for genomic structural variation , 2010, Nature Genetics.

[27]  L. Feuk,et al.  Diagnostic interpretation of array data using public databases and internet sources , 2012, Human mutation.

[28]  Anne-Marie Cleton-Jansen,et al.  Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours , 2010, BMC Research Notes.

[29]  J. Kitzman,et al.  Acquired copy number alterations in adult acute myeloid leukemia genomes , 2009, Proceedings of the National Academy of Sciences.

[30]  A. Neri,et al.  A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect , 2009, Genes, chromosomes & cancer.

[31]  Cheng Li,et al.  Prognostic significance of copy-number alterations in multiple myeloma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  C. O'keefe,et al.  Application of array‐based whole genome scanning technologies as a cytogenetic tool in haematological malignancies , 2009, British journal of haematology.

[33]  J. Maciejewski,et al.  Updates in Cytogenetics and Molecular Markers in MDS , 2011, Current hematologic malignancy reports.

[34]  C. Evers,et al.  Comprehensive array CGH of normal karyotype myelodysplastic syndromes reveals hidden recurrent and individual genomic copy number alterations with prognostic relevance , 2011, Leukemia.

[35]  T. Shaikh,et al.  Implementation of high resolution single nucleotide polymorphism array analysis as a clinical test for patients with hematologic malignancies. , 2011, Cancer genetics.

[36]  H. Fiegler,et al.  Guidelines for molecular karyotyping in constitutional genetic diagnosis , 2007, European Journal of Human Genetics.

[37]  M. McDevitt,et al.  New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[39]  A. Kohlmann,et al.  An accumulation of cytogenetic and molecular genetic events characterizes the progression from MDS to secondary AML: an analysis of 38 paired samples analyzed by cytogenetics, molecular mutation analysis and SNP microarray profiling , 2011, Leukemia.

[40]  P. Ouillette,et al.  The Prognostic Significance of Various 13q14 Deletions in Chronic Lymphocytic Leukemia , 2011, Clinical Cancer Research.

[41]  A. Kohlmann,et al.  Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance , 2011, Leukemia.

[42]  C. Mullighan,et al.  Genomic profiling of high-risk acute lymphoblastic leukemia , 2010, Leukemia.

[43]  G. Morgan,et al.  A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. , 2010, Blood.

[44]  E. Estey,et al.  Continuing medical education activity in American Journal of Hematology , 2011 .

[45]  M. Loh,et al.  Accurate Detection of Uniparental Disomy and Microdeletions by SNP Array Analysis in Myelodysplastic Syndromes with Normal Cytogenetics , 2009, Leukemia.

[46]  Johan Staaf,et al.  Detection of submicroscopic constitutional chromosome aberrations in clinical diagnostics: a validation of the practical performance of different array platforms , 2008, European Journal of Human Genetics.